MedPath

Coagulation Factors Alterations in Patients Undergoing Complex Thoraco-abdominal Aortic Aneurysm Repair

Not yet recruiting
Conditions
Platelet Activation
Thoraco-abdominal Aortic Aneurysm Repair
Coagulation Factors Alterations
Registration Number
NCT06432387
Lead Sponsor
University of Thessaly
Brief Summary

This study will evaluate the impact of complex thoraco-abdominal aortic aneurysm repair in coagulation during the immediate postoperative period in patients undergoing omplex thoraco-abdominal aortic aneurysm repair.

Detailed Description

Endovascular aneurysm repair of abdominal aorta activates a significant inflammation reaction and has an impact on coagulation. Platelet activation seems to have a major role in this prothrombotic and hypercoagulable state. In complex thoraco-abdominal aortic aneurysm repair the implants are more complexed and the duration of operation longer. The main hypothesis is that all the above have a greater impact on platelet activation and coagulation alterations.

The aim of this study is the evaluation of the impact of complex thoraco-abdominal aortic aneurysm repair in coagulation during the immediate postoperative period in patients undergoing omplex thoraco-abdominal aortic aneurysm repair.

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
58
Inclusion Criteria
  • Consecutive patients undergoing complex thoraco-abdominal aortic aneurysm repair in University Hospital of Larissa, after informed consent will be included.
Exclusion Criteria
  • Refuse to participate
  • Prior surgery within 3 months
  • ASA PS > 3
  • Known medical history of thrombophilia or functional platelet dysfunction

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Acute kidney injuryDay of surgery, 1st postoperative day, 4-5th postoperative day

Early preoperatively, early and late postoperatively

Post-implantation syndromeDay of surgery, 1st postoperative day, 4-5th postoperative day

Early preoperatively, early and late postoperatively

Major cardiovascular eventsDay of surgery, 1st postoperative day, 4-5th postoperative day

Early preoperatively, early and late postoperatively

Major cardiovascular events, implant failure and death of any cause30 days, 3, 6, and 12 months postoperatively

Early preoperatively, early and late postoperatively and 1 at one month

Coagulation statusDay of surgery, 1st postoperative day, 4-5th postoperative day

Early preoperatively, early and late postoperatively

Myocardial injury after non cardiac surgeryDay of surgery, 1st postoperative day, 4-5th postoperative day

Early preoperatively, early and late postoperatively

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

University of Thessaly

🇬🇷

Larissa, Greece

University of Thessaly
🇬🇷Larissa, Greece

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.